At a glance
- Originator Unknown
- Developer Toa Eiyo
- Class Antiplatelets
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 03 Nov 2003 Discontinued - Preclinical for Thrombosis in Japan (unspecified route)
- 09 Oct 2001 Profile reviewed but no significant changes made
- 20 Jul 1998 Preclinical development for Thrombosis in Japan (Unknown route)